CBOE GLOBAL MARKETS INC

Explore CBOE’s upcoming binary performance contracts—new derivative tools that let investors bet on corporate metrics, with retail access via Robinhood.

Onco‑Innovations and Redwood AI secure a Terry Fox grant, fast‑tracking AI‑driven precision oncology while cutting costs and regulatory risk—key insight for investors seeking next‑gen biotech exposure.

On 22 Sep 2026, CBOE Global Markets shares repurchase activity and iShares ETF NAV growth highlight disciplined capital strategy and regulatory compliance.

FCA’s September 1, 2026 update reshapes UK securities, adding preference‑share‑linked notes, structured products and corporate bonds while delisting legacy trusts, guiding investors toward hybrid, cross‑border opportunities.

Explore how CBOE Global Markets is expanding leveraged ETFs and driving shareholder value amid volatile liquidity and regulatory scrutiny.

IWG and Babcock’s 18‑Aug 2026 share‑buybacks boost EPS and signal robust capital allocation amid flexible‑workspace growth and rising EU defence spending.

SEC eyes Cboe’s 3× leveraged commodity & crypto ETFs—gold, silver, oil, gas, Bitcoin, Ether—to meet growing institutional demand while navigating new regulatory paths.

Explore how Cboe Global Markets’ 19% dividend boost, insider trades, and a proposed 3× crypto‑commodity ETF could reshape investor returns and regulatory focus.

BlackRock Canada launches low‑cost, single‑ticker ETFs—iShares Equity + Bitcoin Portfolio (IBQT) and iShares Core MSCI All‑International Equity (XINT)—offering Canadian investors streamlined global diversification and a controlled Bitcoin exposure f…

Explore how Cboe Global Markets’ low VIX, booming call‑option volume, and new leveraged ETF lineup reveal hidden arbitrage and tactical growth opportunities for institutional investors.